Reduced differentiation potential of primary MyoD-/- myogenic cells derived from adult skeletal muscle

Journal of Cell Biology

Volumn 144, Issue 4, 1999, Pages 631-643

  Sabourin, Luc A ^a   Girgis Gabardo, Adele ^a   Scale, Patrick ^a   Asakura, Atsushi ^a   Rudnicki, Michael A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Differentiation; MyoD; Myogenic regulatory factor; Proliferation; Satellite cell

Indexed keywords

CADHERIN; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; GENE EXPRESSION; MOUSE; MUSCLE CELL; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; GENE EXPRESSION; LAC OPERON; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; MYOD PROTEIN; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-MET; REGENERATION; RNA, MESSENGER;

ANIMALIA;

EID: 0033593785     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.144.4.631     Document Type: Article

References (60)

1. Allen, R.E., S.M. Sheehan, R.G. Taylor, T.L. Kendall, and G.M. Rice. 1995. Hepatocyte growth factor activates quiescent skeletal muscle satellite cells in vitro. J. Cell. Physiol. 165:307-312.
2. Bader, D., T. Masaki, and D.A. Fischman. 1982. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol. 95:763-770.
3. Barth, A.I., I.S. Nathke, and W.J. Nelson. 1997. Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. Curr. Opin. Cell Biol. 9:683-690.
4. Birnboim, H.C. 1988. Rapid extraction of high molecular weight RNA from cultured cells and granulocytes for Northern analysis. Nucleic Acids Res. 16: 1487-1497.
5. Bischoff, R. 1994. The satellite cell and muscle regeneration. In Myogenesis. Vol. 2. A.G. Engel and C. Franszini-Armstrong, editors. McGraw-Hill Inc., New York. 97-118.
6. Braun, T., M.A. Rudnicki, H.H. Arnold, and R. Jaenisch. 1992. Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death. Cell. 71:369-382.
7. Brennan, T.J., D.G. Edmondson, and E.N. Olson. 1990. Aberrant regulation of MyoD1 contributes to the partially defective myogenic phenotype of BC3H1 cells. J. Cell Biol. 110:929-937.
8. Butz, S., J. Stappert, H. Weissig, and R. Kemler. 1992. Plakoglobin and beta-catenin: distinct but closely related. Science. 257:1142-1144.
9. Cornelison, D.D., and B.J. Wold. 1997. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev. Biol. 191:270-283.
10. Cossu, G., P. Cicinelli, C. Fieri, M. Coletta, and M. Molinaro. 1985. Emergence of TPA-resistant "satellite" cells during muscle histogenesis of human limb. Exp. Cell Res. 160:403-411.
11. DeChiara, T.M., D.C. Bowen, D.M. Valenzuela, M.V. Simmons, W.T. Poueymirou, S. Thomas, E. Kinetz, D.L. Compton, E. Rojas, J.S. Park, et al. 1996. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell. 85:501-512.
12. el-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAFI, a potential mediator of p53 tumor suppression. Cell. 75:817-825.
13. Engert, J.C., E.B. Berglund, and N. Rosenthal. 1996. Proliferation precedes differentiation in IGF-I-stimulated myogenesis. J. Cell Biol. 135:431-440.
14. Ewton, D.Z., S.L. Roof, K.A. Magri, F.J. McWade, and J.R. Florini. 1994. IGF-II is more active than IGF-I in stimulating L6A1 myogenesis: greater mitogenic actions of IGF-I delay differentiation. J. Cell Physiol. 161:277-284.
15. Fan, Y., M. Maley, M. Beilharz, and M. Grounds. 1996. Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve. 19:853-860.
16. George-Weinstein, M., R.F. Foster, J.V. Gerhart, and S.J. Kaufman. 1993. In vitro and in vivo expression of alpha 7 integrin and desmin define the primary and secondary myogenic lineages. Dev. Biol. 156:209-229.
17. Guo, K., J. Wang, V. Andres, R.C. Smith, and K. Walsh. 1995. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell Biol. 15:3823-3829.
18. Gussoni, E., H.M. Blau, and L.M. Kunkel. 1997. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat. Med. 3:970-977.
19. Halevy, O., B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, and A.B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science. 267:1018-1021.
20. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:805-816.
21. Hughes, S.M., and H.M. Blau. 1990. Migration of myoblasts across basal lamina during skeletal muscle development. Nature. 345:350-353.
22. Huttenlocher, A., M. Lakonishok, M. Kinder, S. Wu, T. Truong, K.A. Knudsen, and A.F. Horwitz. 1998. Integrin and cadherin synergy regulates contact inhibition of migration and motile activity. J Cell Biol. 141:515-526.
23. Irintchev, A., M. Zeschnigk, A. Starzinski-Powitz, and A. Wernig. 1994. Expression pattern of M-cadherin in normal, denervated, and regenerating mouse muscles. Dev. Dyn. 199:326-337.
24. Kablar, B., K. Krastel, C. Ying, A. Asakura, S.J. Tapscott, and M.A. Rudnicki. 1997. MyoD and Myf-5 differentially regulate the development of limb versus trunk skeletal muscle. Development (Camb.). 124:4729-4738.
25. LaBaer, J., M.D. Garrett, L.F. Stevenson, J.M. Slingerland, C. Sandhu, H.S. Chou, A. Fattaey, and E. Harlow. 1997. Neu functional activities for the p21 family of CDK inhibitors. Genes Dev. 11:847-862.
26. LeCouter, J.E., P.F. Whyte, and M.A. Rudnicki. 1996. Cloning and expression of the Rb-related mouse p130 mRNA. Oncogene. 12:1433-1440.
27. Lefaucheur, J.P., and A. Sebille. 1995. Muscle regeneration following injury can he modified in vivo by immune neutralization of basic fibroblast growth factor, transforming growth factor beta 1 or insulin-like growth factor 1. J. Neuroimmunol. 57:85-91.
28. Liu, L., P.H. Vachon, W. Kuang, H. Xu, U.M. Wewer, P. Kylsten, and E. Engvall. 1997. Mouse adhalin: primary structure and expression during late stages of muscle differentiation in vitro. Biochem. Biophys. Res. Commun. 235:227-235.
29. Maniatis, T., E.F. Fritsch, and J. Sambrook. 1982. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor. New York. 545 pp.
30. Megency, L.A., and M.A. Rudnicki. 1995. Determination versus differentiation and the MyoD family of transcription factors. Biochem. Cell Biol. 73:723-732.
31. Megency, L.A., B. Kablar, K. Garrett, J.E. Anderson, and M.A. Rudnicki. 1996. MyoD is required for myogenic stem cell function in adult skeletal muscle, Genes Dev. 10:1173-1183.
32. Miller, J.B. 1990. Myogenic programs of mouse muscle cell lines: expression of myosin heavy chain isoforms. MyoD1. and myogenin. J. Cell Biol. 111:1149-1159.
33. Miller, J.R., and R.T. Moon. 1996. Signal transduction through beta-catenin and specification of cell fate during embryogenesis. Genes Dev. 10:2527-2539.
34. Montanas, D., F. Aurade, T. Johnson, J. Han, F. Gros, and C. Pinset. 1996. Autonomous differentiation in the mouse myogenic cell line, C2. involves a mutual positive control between insulin-like growth factor II and MyoD. operating as early as at the myoblast stage. J. Cell Sci.. 109:551-560.
35. Nabeshima, Y., K. Hanaoka, M. Hayasaka, E. Esumi, S. Li, and I. Nonaka. 1993. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature. 364:532-535.
36. Novak, A., S.C. Hsu, C. Leung-Hagesteijn, G Radeva, J. Papkoff, R. Montesano, C. Roskelley, R. Grosschedl, and S. Dedhar. 1998. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc. Natl. Acad. Sci. USA. 95:4374-4379.
37. Olson, E.N. 1992. Interplay between proliferation and differentiation within the myogenic lineage. Dev. Biol. 154:261-272.
38. Patapoutian, A., J.K. Yoon, J.H. Miner, S. Wang, K. Stark, and B. Wold. 1995. Disruption of the mouse MRF4 gene identities multiple waves of myogenesis in the myotome. Development. 121:3347-3358.
39. Peterson, C.A., and J.D. Houle. 1997. Transcription factor polyomavirus enhancer activator protein 3 (PEA3) is induced in adult rats following muscle injury. J. Nutr. 127(Suppl.):1007-1010.
40. Phillips, G.D., J.R. Hoffman, and D.R. Knighton. 1990. Migration of myogenic cells in the rat extensor digitorum longus muscle studied with a split autograft model. Cell Tissue Res. 262:81-88.
41. Phi-Van, L., and W.H. Stratling. 1996. Dissection of the ability of the chicken lysozyme gene 5′ matrix attachment region to stimulate transgene expression and to dampen position effects. Biochemistry. 35:10735-10742.
42. Pouliot, Y., M. Gravel, and P.C. Holland. 1994 Developmental regulation of M-cadherin in the terminal differentiation of skeletal myoblasts. Dev. Dyn. 200:305-312.
43. Ouinn, L.S., and J.S. Roh. 1993. Overexpression of the human type-1 insulin-like growth factor receptor in rat L6 myoblasts induces ligand-dependent cell proliferation and inhibition of differentiation. Exp. Cell Res. 208:504-508.
44. Radeva, G., T. Petrocelli, E. Behrend, C. Leung-Hagesteijn, J. Filmus, J. Slingerland, and S. Dedhar. 1997. Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression. J. Biol. Chem. 272: 13937-13944.
45. Roberds, S.L., F. Letureq, V. Allamand, F. Piccolo, M. Jeanpierre, R.D. Anderson, L.E. Lim, J.C. Lee, F.M. Tome, N.B. Romero, et al. 1994. Missense mutalions in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell. 78:625-633.
46. Rudnicki, M.A., and R. Jaenisch. 1995. The MyoD family of transcription factors and skeletal myogenesis. Bioessays. 17:203-209.
47. Rudnicki, M.A., T. Braun, S. Hinuma, and R. Jaenisch. 1992. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell. 71:383-390.
48. Rudnicki, M.A., P.N. Schnegelsberg, R.H. Stead, T. Braun, H.H. Arnold, and R. Jaenisch. 1993. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell. 75:1351-1359.
49. Skapek, S.X., J. Rhee, D.B. Spicer, and A.B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science. 267:1022-1024.
50. Smith, C.K., 2nd. M.J. Janney, and R.E. Allen. 1994. Temporal expression of myogenic regulatory genes during activation, proliferation, and differentiation of ral skeletal muscle satellite cells. J. Cell Physiol. 159:379-385.
51. Taubman, M.B., C.W. Smith, S. Izumo, J.W. Grant, T. Endo, A. Andreadis, and B. Nadal-Ginard. 1989. The expression of sarcomeric muscle-specific contractile protein genes in BC3H1 cells: BC3H1 cells resemble skeletal myoblasts that are defective for commitment to terminal differentiation. J. Cell Biol. 108:1799-1806.
52. Taylor, J.M., E.E. Dupont-Versteegden, J.D. Davies, J.A. Hassell, J.D. Houle, C.M. Gurley, and C.A. Peterson. 1997. A role for the ETS domain transcription factor PEA3 in myogenic differentiation. Mol Cell Biol. 17:5550-5558.
53. Trimble, M.S., J.H. Xin, C.T. Guy, W.J. Muller, and J.A. Hassell. 1993. PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas. Oncogene. 8:3037-3042.
54. Weintraub, H., R. Davis, S. Tapscott, M. Thayer, M. Krause, R. Benezra, T.K. Blackwell, D. Turner, R. Rupp, S. Hollenberg, et al. 1991. The myoD gene family: nodal point during specification of the muscle cell lineage. Science. 251:761-766.
55. Xin, J.H., A. Cowie, P. Lachance, and J.A. Hassell. 1992. Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells. Genes Dev. 6:481-496.
56. Yablonka-Reuveni, Z., and A.J. Rivera. 1994. Temporal expression of regulatory and structural muscle proteins during myogenesis of satellite cells on isolated adult rat fibers. Dev. Biol. 164:588-603.
57. Yamori, T., Y. Iizuka, Y. Takayama, S. Nishiya, S. Iwashita, A. Yamazaki, T. Takatori, and T. Tsuruo. 1991. Insulin-like growth factor I rapidly induces tyrosine phosphorylation of a Mr 150,000 and a Mr 160,000 protein in highly metastatic mouse colon carcinoma 26 NL-17 cells. Cancer Res. 51:5859-5865.
58. Zeschnigk, M., D. Kozian, C. Kuch, M. Schmoll, and A. Starzinski-Powitz. 1995. Involvement of M-cadherin in terminal differentiation of skeletal muscle cells. J. Cell Sci. 108:2973-2981.
59. Zhang, W., R.R. Behringer, and E.N. Olson. 1998. Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies. Genes Dev. 9:1388-1399.
60. Zhu, A.J., and F.M. Watt. 1996. Expression of a dominant negative cadherin mutant inhibits proliferation and stimulates terminal differentiation of human epidermal keratinocytes. J. Cell Sci. 109:3013-3023.